According to Gram Research analysis, people with CVID who have sufficient vitamin D levels are significantly less likely to develop atelectasis, a condition where lung tissue collapses. In a study of 48 CVID patients, only 23% of those with healthy vitamin D levels had atelectasis compared to 43% of those with low vitamin D. However, this cross-sectional study shows only an association, not proof that vitamin D prevents lung collapse, so larger studies are needed to confirm the finding
Researchers studied 48 adults with CVID, a rare condition where the immune system doesn’t work properly. They found that people with healthy vitamin D levels were less likely to develop atelectasis, a condition where part of the lung collapses. While 73% of patients had low vitamin D, those with sufficient levels had significantly fewer cases of lung collapse. However, this was a small study that only shows a connection, not proof that vitamin D prevents the problem. Larger studies are needed to confirm whether boosting vitamin D actually helps prevent this serious lung complication.
Key Statistics
A cross-sectional study of 48 CVID patients published in 2026 found that 73% had insufficient vitamin D levels (below 30 ng/mL), and atelectasis was significantly more common in this group at 43% compared to 23% in those with sufficient vitamin D.
Among 48 adults with CVID, those with sufficient vitamin D had approximately 77% lower odds of developing atelectasis compared to those with insufficient levels (odds ratio=0.12, P=0.02).
In the 2026 cross-sectional study of CVID patients, vitamin D sufficiency was associated with reduced atelectasis prevalence, though no significant associations were found for other lung complications including bronchiectasis, recurrent pneumonia, or COPD.
The Quick Take
- What they studied: Whether vitamin D levels affect lung problems in people with CVID, a rare immune system disorder that makes it hard to fight infections
- Who participated: 48 adult patients with CVID. The researchers split them into two groups based on vitamin D blood levels: those with low levels (below 30 ng/mL) and those with healthy levels (30 ng/mL or higher)
- Key finding: People with sufficient vitamin D had much lower rates of atelectasis (lung collapse). Only 23% of the sufficient group had atelectasis compared to 43% of the insufficient group. This difference was statistically significant (P=0.02)
- What it means for you: If you have CVID, maintaining healthy vitamin D levels might help protect your lungs from collapse. However, this study only shows a connection, not proof of cause and effect. Talk to your doctor about checking your vitamin D levels and whether supplementation is right for you
The Research Details
This was a cross-sectional study, which means researchers looked at a group of people at one point in time rather than following them over months or years. They reviewed medical records of 48 adults with CVID and divided them into two groups based on their vitamin D blood levels. The researchers then checked which patients had developed atelectasis (collapsed lung tissue) and other lung problems.
The study used a specific cutoff point for vitamin D: 30 ng/mL. Patients with levels below this were considered insufficient, while those at or above this level were considered sufficient. The researchers used a statistical test called Fisher’s exact test to see if the differences between groups were real or just due to chance.
They also created Kaplan-Meier curves, which are graphs that show how long patients stayed free from atelectasis based on their starting vitamin D levels. This helped them visualize whether vitamin D status predicted long-term lung health.
This research approach is important because CVID is a rare condition, making it hard to study large numbers of patients. By looking at existing medical records, researchers could gather information without putting patients through additional testing. The cross-sectional design allowed them to spot potential connections between vitamin D and lung problems quickly, which can guide future research. However, this type of study can only show associations, not prove that one thing causes another.
This study has several important limitations to understand. First, it’s small with only 48 patients, so the results might not apply to all CVID patients. Second, it’s cross-sectional, meaning it captures one moment in time rather than following patients over years. Third, the researchers couldn’t prove that low vitamin D causes atelectasis, only that they tend to occur together. The study was also retrospective, relying on medical records that may not have complete information. Finally, the Kaplan-Meier curves didn’t show clear separation between groups, suggesting the connection might be more complex than it appears
What the Results Show
Among the 48 patients studied, 35 (73%) had insufficient vitamin D levels (below 30 ng/mL), while 13 (27%) had sufficient levels. This shows that low vitamin D is very common in CVID patients. The key finding was that atelectasis occurred much more frequently in the insufficient group: 43% of patients with low vitamin D had lung collapse compared to only 23% of those with sufficient vitamin D.
The statistical analysis showed this difference was real and not due to chance (odds ratio=0.12, P=0.02). This means having sufficient vitamin D was associated with about 77% lower odds of having atelectasis. However, the researchers emphasized this shows a connection, not proof that vitamin D prevents lung collapse.
Interestingly, vitamin D status did not appear to affect other lung problems studied. Bronchiectasis (permanent lung damage) occurred in 63% of the insufficient group versus 46% of the sufficient group, but this difference wasn’t statistically significant. Recurrent pneumonia was common in both groups (91% insufficient, 84% sufficient), and COPD was rare in both (3% insufficient, 8% sufficient).
The study found that atelectasis was the only lung complication clearly associated with vitamin D status. Bronchiectasis, recurrent pneumonia, and COPD showed no significant differences between groups. The Kaplan-Meier curves, which tracked how long patients stayed free from atelectasis, did not show a clear separation between the two vitamin D groups over time. This suggests the relationship between vitamin D and atelectasis might be more complicated than a simple cause-and-effect relationship. The researchers noted that other factors not measured in this study might also influence whether patients develop lung collapse.
Vitamin D has been linked to lung health in other populations, including people with asthma, tuberculosis, and general respiratory infections. This study extends that research to CVID, a rare immune disorder. The finding that vitamin D sufficiency is associated with fewer cases of atelectasis aligns with the general understanding that vitamin D supports immune function and lung health. However, this is one of the first studies to specifically examine this connection in CVID patients, so it adds new information to a relatively understudied area.
This study has several important limitations. The sample size of 48 patients is small, which limits how much we can generalize the findings to all CVID patients. The cross-sectional design means researchers looked at patients at one point in time, not following them over years to see if vitamin D actually prevents atelectasis from developing. The study is retrospective, relying on medical records that may be incomplete or inaccurate. The researchers could not control for other factors that might affect lung health, such as infection history, medication use, or genetic differences. The Kaplan-Meier curves did not show clear separation between groups, which weakens confidence in the findings. Finally, this study shows association only, not causation, so we cannot conclude that low vitamin D causes atelectasis
The Bottom Line
If you have CVID, ask your doctor to check your vitamin D levels. If your level is below 30 ng/mL, discuss vitamin D supplementation. The evidence for vitamin D helping prevent lung collapse in CVID is moderate at this stage, based on one small cross-sectional study. This is not yet strong enough to make it a standard treatment, but it’s worth discussing with your healthcare team. Larger, longer-term studies are needed before making firm recommendations. In the meantime, maintaining overall lung health through infection prevention and regular medical monitoring remains important
This research is most relevant to adults with CVID who are concerned about lung complications. It may also interest immunologists and pulmonologists who treat CVID patients. People with other immune disorders might find this interesting, but the findings apply specifically to CVID. If you don’t have CVID, this study doesn’t directly apply to you, though maintaining healthy vitamin D levels is generally recommended for overall health
This study doesn’t tell us how quickly vitamin D supplementation might help. It’s a snapshot of patients at one point in time, not a study tracking changes over months or years. If vitamin D does help prevent atelectasis, it likely works gradually over time as part of supporting overall immune and lung function. You shouldn’t expect immediate results from vitamin D supplementation. Talk to your doctor about realistic timelines for any health improvements
Frequently Asked Questions
Does vitamin D prevent lung collapse in people with CVID?
Research shows an association between sufficient vitamin D and lower atelectasis rates in CVID patients, but this study cannot prove vitamin D prevents lung collapse. A 2026 study of 48 CVID patients found 43% with low vitamin D had atelectasis versus 23% with sufficient levels. Larger studies are needed to confirm causation
What vitamin D level should I aim for if I have CVID?
This study used 30 ng/mL as the cutoff for sufficient vitamin D. However, your doctor may recommend a different target based on your individual health needs. Ask your healthcare provider what vitamin D level is right for you and whether supplementation is appropriate
How common is low vitamin D in people with CVID?
Very common. In this 2026 study of 48 CVID patients, 73% had insufficient vitamin D levels below 30 ng/mL. This suggests vitamin D deficiency is a widespread issue in the CVID population that deserves attention
Can vitamin D supplementation help other lung problems in CVID?
This study found vitamin D was associated only with atelectasis, not with bronchiectasis, recurrent pneumonia, or COPD in CVID patients. Vitamin D may help prevent lung collapse specifically, but the research doesn’t support benefits for other lung complications
Should I start taking vitamin D supplements if I have CVID?
Talk to your doctor before starting supplements. While this research suggests a potential benefit, it’s based on one small study showing association, not proof of benefit. Your doctor can check your vitamin D level and recommend supplementation if appropriate for your situation
Want to Apply This Research?
- Track your vitamin D blood levels quarterly (every 3 months) if you have CVID. Record the specific number in ng/mL and note whether it’s below 30 (insufficient) or 30 and above (sufficient). Also track any respiratory symptoms like shortness of breath or chest discomfort
- If your doctor recommends vitamin D supplementation, use the app to set daily reminders to take your supplement at the same time each day. Log when you take it to maintain consistency. Set a reminder for your next vitamin D blood test so you can track whether supplementation is raising your levels
- Create a long-term tracking dashboard showing your vitamin D levels over time alongside any respiratory symptoms or lung-related health events. This helps you and your doctor see if there’s a pattern between vitamin D status and lung health. Share this data with your healthcare team at each visit to inform treatment decisions
This article summarizes research findings but is not medical advice. CVID is a serious medical condition requiring specialized care from an immunologist. Do not start, stop, or change any supplements or treatments without consulting your doctor. The findings presented show an association between vitamin D and atelectasis in CVID patients but do not prove causation. This was a small cross-sectional study with limitations. Always work with your healthcare team to make decisions about your health based on your individual situation
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.